22 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
1
Novel P2 tris-tetrahydrofuran group in antiviral compound 1 (GRL-0519) fills the S2 binding pocket of selected mutants of HIV-1 protease.
Georgia State University
43
Design, synthesis, and biological and structural evaluations of novel HIV-1 protease inhibitors to combat drug resistance.
Sanford-Burnham Medical Research Institute
2
Potent antiviral HIV-1 protease inhibitor GRL-02031 adapts to the structures of drug resistant mutants with its P1'-pyrrolidinone ring.
Georgia State University
9
Synthesis and structural studies of pentacycloundecane-based HIV-1 PR inhibitors: a hybrid 2D NMR and docking/QM/MM/MD approach.
University of Kwazulu-Natal
10
Proteochemometrics mapping of the interaction space for retroviral proteases and their substrates.
Uppsala University
33
HIV-1 protease inhibitors with a transition-state mimic comprising a tertiary alcohol: improved antiviral activity in cells.
Uppsala University
3
Solution kinetics measurements suggest HIV-1 protease has two binding sites for darunavir and amprenavir.
Georgia State University
7
Inorganic polyhedral metallacarborane inhibitors of HIV protease: a new approach to overcoming antiviral resistance.
Academy of Sciences of The Czech Republic
2
Potent new antiviral compound shows similar inhibition and structural interactions with drug resistant mutants and wild type HIV-1 protease.
Georgia State University
46
Protein kinase inhibitors, preparation method and medical use thereof
Gan & Lee Pharmaceuticals
11
The amylase inhibitor montbretin A reveals a new glycosidase inhibition motif.
University of British Columbia
85
Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors.
University of California Berkeley
5
Novel antagonists of the thioesterase domain of human fatty acid synthase.
Burnham Institute For Medical Research
9
Enantiospecificity of glutamate carboxypeptidase II inhibition.
Guilford Pharmaceuticals